Compare RGEN & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | HOMB |
|---|---|---|
| Founded | 1981 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.3B |
| IPO Year | 1995 | 2006 |
| Metric | RGEN | HOMB |
|---|---|---|
| Price | $120.16 | $28.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 5 |
| Target Price | ★ $172.91 | $32.40 |
| AVG Volume (30 Days) | 827.6K | ★ 1.2M |
| Earning Date | 04-28-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 2.94% |
| EPS Growth | ★ 286.96 | 19.90 |
| EPS | 0.86 | ★ 2.41 |
| Revenue | ★ $141,236,000.00 | N/A |
| Revenue This Year | $14.30 | $10.99 |
| Revenue Next Year | $14.52 | $5.14 |
| P/E Ratio | $139.53 | ★ $11.85 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $109.66 | $24.98 |
| 52 Week High | $175.77 | $30.83 |
| Indicator | RGEN | HOMB |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 58.67 |
| Support Level | $111.29 | $27.68 |
| Resistance Level | $131.81 | $28.74 |
| Average True Range (ATR) | 4.70 | 0.51 |
| MACD | 1.58 | 0.27 |
| Stochastic Oscillator | 79.74 | 72.86 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The company has one reportable segment: The Banking Segment.